Pharmacognosy Research logo
Submit
Pharmacognosy ResearchACADEMIC PUBLISHING
Article

In silico Exploration of Gmelina asiatica for Multitarget Neuroprotection in Alzheimer's Disease

1, 2, 1, 1★★ Corresponding author

  1. 1Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, INDIA.
  2. 2Department of Pharmacognosy, GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, Andhra Pradesh, INDIA.

CORRESPONDENCE

Siva Hemalatha

Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, INDIA.

shemalatha.phe@itbhu.ac.in

Received: 22-09-2024; Accepted: 03-12-2024.

Volume 17, Issue 1 · pp. 115-125 · 2025 · DOI: 10.5530/pres.20251950

ABSTRACT

Gmelina asiatica, commonly known as Asian Bushbeach, has traditionally been used for neurological disorders. To identify the phytoconstituents activity in Alzheimer's disease through in silico approach. The following targets AChE, BACE1, GSK-3, and TACE1 were selected based on AD pathophysiology for in silico studies. The listed phytoconstituents were docked and MD simulations were carried out using Auto Dock and Desmond-maestro, respectively. Further, DFT studies were performed using Gaussview software. Among all listed ligands, isorhoifolin was identified as the most effective compound based on binding scores of AChE (-10.9 kcal/mol), BACE1 (-10.2 kcal/mol), GSK-3 (-9.7 kcal/mol), and TACE1 (-9 kcal/mol). Further, molecular dynamics simulations of BACE1-isorhoifolin and AChE-isorhoifolin complexes demonstrated stability for up to 200 ns. Density Functional Theory (DFT) studies indicated isorhoifolin have energy gap of -0.162 eV along with that electrostatic potential surface map indicates its good reactivity and charge distribution. Additionally, ADMET analysis confirmed that isorhoifolin have drug-likeness properties and safe for human biological system. These study findings suggest that isorhoifolin from Gmelina asiatica may have potential anti-Alzheimer's activity meriting further biological evaluations.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Andarghiske, K. R., Bhanukiran, K., Ksirri, R., & Hemalatha, S. (2025). In silico Exploration of Gmelina asiatica for Multitarget Neuroprotection in Alzheimer's Disease. Pharmacognosy Research, 17(1), 115-125. https://doi.org/10.5530/pres.20251950

    Copyright and licence

    © 2025 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0